Author:
Thun Michael J.,Jacobs Eric J.,Patrono Carlo
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U. S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 150, 396–404 (2009).
2. Graham, I. et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. J. Cardiovasc. Prev. Rehabil. 14 (Suppl. 2), S1–S113 (2007).
3. US Preventive Services Task Force. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colourecolorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 146, 361–364 (2007).
4. Patrono, C., Garcia Rodriguez, L. A., Landolfi, R. & Baigent, C. Low-dose aspirin for the prevention of atherothrombosis. N. Engl. J. Med. 353, 2373–2383 (2005).
5. Rothwell, P. M. et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet
http://dx.doi.org/10.1016/S0140-6736(11)61720-0
.
Cited by
422 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献